Akèy › Kansè nan tete › Michigan › Lansing
Etid klinik pou Kansè nan tete nan Lansing, MI
10 etid pou Kansè nan tete ap chèche patisipan nan sit nan ak bò kote Lansing (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- University of Michigan Health - Sparrow Lansing, Lansing
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Ap rekriteFaz 3
- Karmanos Cancer Institute at McLaren Greater Lansing, Lansing
- University of Michigan Health - Sparrow Lansing, Lansing
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Ap rekriteFaz 3
- Karmanos Cancer Institute at McLaren Greater Lansing, Lansing
E-Mindfulness Approaches for Living After Breast Cancer
Ap rekriteFaz 3
- University of Michigan Health - Sparrow Lansing, Lansing
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Ap rekriteFaz 2
- Herbert-Herman Cancer Center, Sparrow Hospital, Lansing
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Ap rekriteFaz 3
- Karmanos Cancer Institute at McLaren Greater Lansing, Lansing
A Study of the TheraBionic P1 Device in Breast Cancer
Ap rekrite
- Karmanos Cancer Institute at McLaren Greater Lansing, Lansing
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Lansing
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Ap rekriteFaz 3
- Karmanos Cancer Institute at McLaren Greater Lansing, Lansing
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Ap rekriteEtid obsèvasyon
- Sparrow Cancer Center, Lansing
Etid Kansè nan tete nan lòt vil
- New York City, NY134 etid
- Houston, TX126 etid
- Boston, MA111 etid
- Nashville, TN80 etid
- Los Angeles, CA72 etid
- Edison, NJ68 etid
- St. Louis, MO64 etid
- Durham, NC63 etid
- Queens, NY63 etid
- Chicago, IL58 etid
- Philadelphia, PA56 etid
- Dallas, TX55 etid
Lòt etid nan Lansing
- Kansè poumon11 etid
- Kansè pwostat10 etid
- Kansè Poumon ki pa ti selil9 etid
- Kansè (tout kalite)6 etid
- Kansè larinks5 etid
- Kansè vejik5 etid
- Twoub Somnolans Eksestif5 etid
- Kansè kolorektal4 etid
- Kansè renn (Kasinom selil renn)4 etid
- Kansè kolon4 etid
- Kasinom Selil Transizyonèl (Urotelyal)4 etid
- Karsinòm selil skuamèz tèt ak kou4 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.